Easton Pharmaceuticals Announces The Appointment Of John Easton As Interim Chief Executive Officer

Posted by on Jun 13, 2011 in News | 0 comments

Toronto, ON – June 13, 2011 –TORONTO, ONTARIO–(Marketwire) – Easton Pharmaceuticals Inc (OTC:EAPH – News), a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products, today announced that Mr. John Easton has been appointed to the position of CEO on an interim basis, enabling the Company’s smooth transition from an early-stage research and development company to a commercial, revenue-producing specialty pharmaceutical company. Mr. Easton stated “I am honored to accept this day to day operating role in the Company. I would also like to thank Mr. Folinski for his work over the past several years in the position and for assisting us in getting the Company to where it is today. Mr Folinski will continue working with the company in the President’s role.” Mr. Easton further stated, “I will work tirelessly for the successful execution of our Business Plan. This includes the continuation of an active selection process for an industry-seasoned CEO as my successor, which we expect to announce the appointment of in a full-time capacity very shortly.”

Mr. Easton is an accomplished entrepreneur who has been instrumental in the successful fundraising and launch of various companies in the healthcare field and related industries whilst being at the helm of multi-million dollar real estate projects in Canada over the past twenty-five years. He also recognized the dynamic growth and untapped market potential in the healthcare field in the area of tissue healing and sexual wellness. He has spent the past eight years managing research projects and has assembled a team of world class medical doctors, researchers and a professional management team to execute Easton Pharmaceuticals’ business objectives. Mr. Easton will provide the vision and direction that will be the foundation of Easton Pharmaceuticals and will continue to serve as Chairman of the Board after the appointment of the Company’s new CEO.

About Easton Pharmaceuticals Inc

Easton Pharmaceuticals is a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products, focused on skin and circulatory conditions that impact a large and expanding numbers of consumers including health issues related to male and female sexual dysfunction, scar and stretch marks, cellulite and varicose veins, the world market for these conditions is in excess of $10 billion. The company’s proprietary gel formulation is an innovative and unique transdermal delivery system. Easton Pharmaceuticals’ flagship product, VIORRA, is an over-the-counter aid for the treatment to restore and improve vaginal moisture and elasticity which has a very positive effect on women’s sexual desire and arousal , FSAD (Female Sexual Arousal Disorder) the world market for these female conditions are in excess of $2 billion. VIORRA is a topical, daily-use product classified by the FDA as containing Generally Recognized as Safe ingredients.

For more information, visit www.eastonpharma.com

Contact:

Easton Pharmaceuticals Inc.
Tel: +1(416) 619-0291+1(416) 619-0291
Tel: +1(347) 284-0192+1(347) 284-0192
Fax: +1(888) 877-3723
Media relations: media@eastonpharma.com
Investor relations: ir@eastonpharma.com

Leave a Reply

Your email address will not be published. Required fields are marked *

* Copy This Password *

* Type Or Paste Password Here *